Companies · Cybersecurity
NEWPORT BEACH · Cybersecurity · refined from filed group “Other”
Diligence memoA one-page analyst read on Titan Health & Security Technologies, Inc. — recommendation, valuation, rhythm, risks.→Titan Health & Security Technologies, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the cybersecurity sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Titan Health & Security Technologies, Inc. is one of 270 Cybersecurity companies tracked from NEWPORT BEACH. By capital raised it ranks in the upper tier (ahead of 75% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.
Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the cybersecurity sector profile. Directional, not a quoted figure.
Benchmarked against 270 companies in Cybersecurity. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 75% of sector peers (real $). Modeled value above 58% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #15 of 17.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Cequence Security, Inc. | Series A | $21.6M | $428.0M | 3.02× |
| Securitize, Inc. | Series A | $24.9M | $386.4M | 2.73× |
| Living Security, Inc. | Series A | $14.0M | $329.0M | 2.32× |
| SecurEnds, Inc. | Series A | $15.0M | $312.2M | 2.20× |
| Threat X, Inc. | Series A | $24.2M | $214.0M | 1.51× |
| Open Inc. | Series A | $5.4M | $170.1M | 1.20× |
| Variance, Inc. | Series A | $5.1M | $160.8M | 1.13× |
| Live Labels Security LLc | Series A | $5.0M | $148.1M | 1.04× |
| Fortress Security Holdings, LLC | Series A | $4.5M | $141.8M | 1.00× |
| Mission Secure, Inc. | Series A | $10.7M | $129.2M | 0.91× |
| Cyberinc Corp | Series A | $15.9M | $116.6M | 0.82× |
| Secured Finance AG | Series A | $4.1M | $98.1M | 0.69× |
| Titan Health & Security Technologies, Inc. this company | Series A | $15.6M | $43.6M | 0.31× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Pre-Seed | $689K | 2016-07-01 | $3.8M | $33.2M | 85% |
| Pre-Seed | $550K | 2016-08-26 | $3.1M | $26.5M | 85% |
| Seed | $1.6M | 2018-10-10 | $7.8M | $60.6M | 90% |
| Series A | $10.3M | 2021-05-07 | $46.7M | $226.3M | 90% |
| Series A | $2.6M | 2021-12-17 | $11.7M | $43.6M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| MICHAEL BEAUDOIN | — | 8 other | 2021-12 |
| Shawn Dougherty | — | 3 other | 2021-12 |
| Jag Setlur | — | 1 other | 2021-12 |
| Ed Merjanian | — | — | 2021-12 |
| Edward A. Merjanian | — | — | 2018-10 |
| Edward Merjanian | — | — | 2016-07 |
| Francis Quinlan | — | — | 2021-12 |
| Michael B. Merjanian | — | — | 2016-07 |
| Ralph B. Kalfayan | — | — | 2016-07 |
| Vahan B. Zanoyan | — | — | 2018-10 |
| Vahan Zanoyan | — | — | 2021-12 |
| Vic A. Merjanian | — | — | 2018-10 |
| Vic Merjanian | — | — | 2016-07 |
Titan Health & Security Technologies, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Bluestone Medical, Inc. | Manufacturing | Series A | $10.2M | $47.4M | network2 shared operators · same stage |
| Vali Cyber, Inc. | Cybersecurity | Series A | $15.7M | $16.5M | same sector · same stage |
| Cyberinc Corp | Cybersecurity | Series A | $15.9M | $116.6M | same sector · same stage |
| Evo Security Technologies, Inc. | Cybersecurity | Series A | $15.2M | $37.7M | same sector · same stage |
| Zilla Security Inc. | Cybersecurity | Series A | $16.1M | $157.5M | same sector · same stage |
| SecurEnds, Inc. | Cybersecurity | Series A | $15.0M | $312.2M | same sector · same stage |
| Rapid Focus Security, Inc. | Cybersecurity | Series A | $16.5M | $252.0M | same sector · same stage |
| Securisyn Medical, LLC | Cybersecurity | Series A | $16.7M | $20.5M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Titan Medical Inc | Healthtech | Seed | $63.0M | 86% |
| Scope Security, Inc. | Cybersecurity | Series B | $405.3M | 82% |
| Nucleus Security, Inc. | Cybersecurity | Series B | $373.6M | 82% |
| Cyber Safety Inc | Cybersecurity | Pre-Seed | $3.7M | 81% |
| Cyberspatial Inc. | Cybersecurity | Seed | $6.6M | 81% |
| Vali Cyber, Inc. | Cybersecurity | Series A | $16.5M | 80% |
| Oso Security Inc. | Cybersecurity | Seed | $106.2M | 80% |
| Cybersyn, Inc. | Cybersecurity | Series C | $911.5M | 80% |
See where Titan Health & Security Technologies, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Titan Health & Security Technologies, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.